GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Quoin Pharmaceuticals
Quoin Pharmaceuticals is a pharmaceutical company specializing in the treatment of rare skin diseases. Its stock price reflects its strategy of developing and commercializing drugs for niche markets with unmet needs.
Share prices of companies in the market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company specializing in developing drugs to treat rare dermatological diseases for which there are no approved treatments. We have classified it in the Pharma: Skin category. The chart below shows the dynamics of the orphan disease sector.
Broad Market Index - GURU.Markets
Quoin Pharmaceuticals is a pharmaceutical company specializing in developing drugs to treat rare dermatological diseases. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
QNRX - Daily change in the company's share price Quoin Pharmaceuticals
For Quoin Pharmaceuticals, Ltd., a dermatology company, daily volatility reflects sensitivity to clinical trial data. This metric is an important element in assessing the risk of companies involved in rare diseases.
Daily change in the price of a set of shares in a market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing treatments for rare skin diseases. This segment has its own unique dynamics. The chart below shows the volatility in this niche, allowing you to compare QNRX stock performance with other market players.
Daily change in the price of a broad market stock, index - GURU.Markets
Quoin Pharmaceuticals is a pharmaceutical company focused on dermatology. Its shares are driven by successful drug commercialization and clinical trial results. The dynamics of this niche healthcare segment are part of a larger and more diverse picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Quoin Pharmaceuticals
For Quoin Pharmaceuticals, the year-to-date performance is a story of developing drugs for rare dermatological diseases. Its 12-month market capitalization is entirely dependent on clinical trial data. The success of its lead candidate for the treatment of Netherton syndrome could lead to the first approved therapy for this devastating condition.
Annual dynamics of market capitalization of the market segment - Pharma skin
Quoin, as an early-stage biotech, is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about clinical trials of its drugs for rare skin diseases. Its stock price will reflect the speculative faith of investors.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Quoin Pharmaceuticals, a pharmaceutical company specializing in rare skin diseases for which there is no effective treatment, operates in a market with a high unmet need. Its annual market capitalization growth depends on its ability to secure regulatory approval and offer hope to patients.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Quoin Pharmaceuticals
Quoin is a pharmaceutical company focused on rare skin diseases. Its monthly performance is driven by clinical and regulatory events. News about interactions with the FDA and progress in its key programs are the main drivers.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Biotechnology targeting rare skin diseases is a niche where a scientific breakthrough can radically change patients' lives. The dynamics of this sector, shown in the graph, reflect the high risks and potential of these developments. Companies like Quoin Pharmaceuticals are conducting research in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Quoin Pharmaceuticals is an early-stage biotech company. Its shares are steeped in lab data and investor expectations about science. Their value can fluctuate wildly, ignoring macroeconomic events and overall market movements.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Quoin Pharmaceuticals
Quoin Pharmaceuticals, a company focused on treating rare skin diseases, is a typical representative of the speculative biotech sector. Its weekly stock price is entirely dependent on news about clinical trials and regulatory decisions, rather than on overall market trends.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare skin diseases. Its strategy is to acquire and develop promising drugs. This chart will help you understand how news about deals and clinical trials impacts its stock price, independent of overall pharma trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare diseases. Its shares move on development news. The chart shows how their performance is uncorrelated with overall market trends and sentiment.
Market capitalization of the company, segment and market as a whole
QNRX - Market capitalization of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals' market capitalization chart reflects investor sentiment on its drugs for rare dermatological diseases. Its dynamics reflect the market's confidence in its lead product, a treatment for Netherton syndrome. Its low valuation reflects both its potential in the orphan disease market and the high risk associated with its development.
QNRX - Share of the company's market capitalization Quoin Pharmaceuticals within the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Its market share is small, but it targets niches without approved treatments. Its market cap is a bet on its ability to secure regulatory approval for its drugs.
Market capitalization of the market segment - Pharma skin
This chart shows the total market capitalization of the entire pharmaceutical sector focused on skin care. For Quoin Pharmaceuticals, which works on rare skin diseases, this line is a map of hope. Its dynamics demonstrate that even in a crowded sector, there is room for companies solving specific but important medical problems.
Market capitalization of all companies included in a broad market index - GURU.Markets
Quoin Pharmaceuticals is a company developing drugs for the treatment of rare dermatological diseases. Its market capitalization is determined by its focus on orphan skin diseases. This market share is determined by its focus on finding solutions for often-overlooked patients.
Book value capitalization of the company, segment and market as a whole
QNRX - Book value capitalization of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a pharmaceutical company specializing in rare diseases. Its book value is its financial resources for research and development, consisting of cash used for clinical trials. How has this research capital changed? The chart below shows.
QNRX - Share of the company's book capitalization Quoin Pharmaceuticals within the market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company focused on rare skin diseases. Its operations require a resource base: laboratories for research and manufacturing facilities for the production of its niche products. The chart shows the company's share of R&D and operational infrastructure in this segment.
Market segment balance sheet capitalization - Pharma skin
Quoin Pharmaceuticals is a biopharmaceutical company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. Quoin focuses on drug development, and its capital lies in its intellectual property and R&D infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Quoin Pharmaceuticals' assets are not factories, but capital and a commercial strategy for developing and commercializing drugs for rare skin diseases for which there are no approved therapies. These assets reflect its financial resources for addressing these niche medical needs.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare skin diseases. Its market capitalization reflects its strategy of developing drugs for patients with few or no other treatment options.
Market to book capitalization ratio in a market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company specializing in the treatment of rare skin diseases. Its high valuation on this chart reflects investors' bet that it will successfully bring drugs to market for patients who currently have no other treatment options.
Market to book capitalization ratio for the market as a whole
Quoin Pharmaceuticals specializes in drugs for rare skin diseases. The company's market value reflects its success in a niche where competition may be low but the need for treatment is high. This chart helps assess how investors view business models focused on orphan diseases.
Debts of the company, segment and market as a whole
QNRX - Company debts Quoin Pharmaceuticals
Quoin, a pharmaceutical company focused on rare skin diseases, is raising capital to fund its clinical trials and prepare for commercialization. This chart shows the financial needs of a company operating in the orphan disease niche, where the path to market is long and expensive.
Market segment debts - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing drugs for rare and orphan diseases for which there are no approved treatments. This chart shows how the company funds its clinical programs, a challenging task given the small patient populations, but also the potential benefits of success.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs for rare and orphan diseases, often in the field of dermatology. Clinical trials for these conditions require significant, though lesser, investment than for mainstream drugs. This chart shows how the company uses debt to finance its niche R&D programs.
Market segment debt to market segment book capitalization - Pharma skin
Quoin Pharmaceuticals is a small pharmaceutical company specializing in drugs for rare skin diseases. This chart shows how the company finances its clinical trials. It compares its debt load to the market capitalization of the entire pharmaceutical sector, reflecting its financial risks.
Debt to book value of all companies in the market
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Developing drugs for small patient populations requires a unique financial model. How dependent is the company on debt? This chart of total market debt provides context for assessing its financial strength.
P/E of the company, segment and market as a whole
P/E - Quoin Pharmaceuticals
Quoin Pharmaceuticals is a pharmaceutical company specializing in developing treatments for rare skin diseases. This chart shows how investors view its niche strategy. The valuation is heavily dependent on clinical trial results and the commercial potential of its products.
P/E of the market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company specializing in developing drugs to treat rare and orphan diseases for which there are no approved treatments. This chart illustrates the average valuation in the pharmaceutical sector, where investors value the high potential and regulatory benefits of orphan drugs.
P/E of the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing drugs to treat rare and orphan diseases for which there are no approved treatments. This chart reflects investors' overall risk appetite. It helps understand whether QNRX's valuation is based on the potential of its niche drugs or whether it moves in line with overall biotech sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare skin diseases for which there are no approved treatments. This chart shows how investors assess the company's chances of success in this challenging niche, where even a single successful drug can generate significant revenue.
%20P%2FE%20Quoin%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Quoin-Pharmaceuticals&v=1772662001142 "Chart of the company's future (projected) P/E Quoin Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs for rare dermatological diseases. This chart reflects future revenue forecasts for the sector. It helps understand the market's confidence in the commercial potential of its niche products and their ability to help patients without alternatives.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772662001165 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare dermatological diseases. This chart of overall risk appetite in the biotech sector shows how willing investors are to fund companies targeting orphan diseases, where competition is lower but the market is limited.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772662001175 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing drugs for rare dermatological diseases. Its financial indicators reflect R&D expenditures. This chart shows investments in addressing patient needs for which effective treatments currently exist.
Profit of companies in the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing drugs for the treatment of rare and orphan diseases for which there are no approved treatments. This chart shows overall profitability in the dermatology pharmaceutical sector, where a focus on niche but critical indications can ensure market exclusivity.
Overall market profit
Quoin Pharmaceuticals is a specialty pharmaceutical company developing treatments for rare skin diseases. The need for these medications is determined by medical indications, not economic conditions. The company's success depends on regulatory approvals, not the macroeconomic trends visible in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs for rare dermatological diseases. Future revenue depends on regulatory approvals and the commercial success of its niche products. This chart reflects analyst expectations for its strategy focused on orphan skin diseases.
%20profit%20of%20the%20company%20Quoin%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Quoin-Pharmaceuticals&v=1772662001208 "Graph of future (projected) profit of the company Quoin Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare and orphan diseases for which there are no effective treatments. Its focus on unmet medical needs is key. This chart shows revenue projections for the dermatology segment, providing context for assessing Quoin's niche strategy.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772662001288 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Quoin Pharmaceuticals is a pharmaceutical company specializing in drugs for the treatment of rare skin diseases. Its revenue depends on the successful commercialization of its products. The overall economic situation, reflected in this chart, affects the ability of patients and the healthcare system to pay, which impacts sales.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772662001299 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare skin diseases for which there are no approved treatments. It has no revenue at the clinical stage. This chart reflects investor assessments of its strategy for addressing unmet medical needs.
P/S market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare and orphan diseases for which there are no approved treatments. Their focus on unmet medical needs offers hope to patients. This chart shows the average revenue estimate for the sector, which helps assess how the market views this business model.
P/S of the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare dermatological diseases. This chart helps us understand that the valuation of such companies is based on their ability to achieve a dominant position in the small but high-margin orphan disease market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing treatments for rare dermatological diseases for which there are no approved therapies. Estimating future revenue is crucial for the company, reflecting investor expectations for the success of its drugs in clinical trials and its ability to achieve leadership in these niche markets.
%20P%2FS%20Quoin%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Quoin-Pharmaceuticals&v=1772662001418 "The graph of the company's future (projected) P/S Quoin Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare and orphan diseases for which there are no effective therapies. This chart compares the company's estimated future sales with industry expectations. It shows how investors view its ability to successfully develop and commercialize drugs for niche markets.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772662001437 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare skin diseases for which there are no approved treatments. The company's success depends on its ability to fill this niche. This market forecast chart reflects investor confidence in its business model focused on orphan (rare) diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772662001443 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Quoin Pharmaceuticals
This metric for Quoin Pharmaceuticals reflects the financial activity of the company, which develops drugs for the treatment of rare skin diseases. Being in the clinical stage, the company may not have stable sales revenue, but may instead rely on licensing agreements for revenue.
Sales of companies in the market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company specializing in developing drugs for the treatment of rare dermatological diseases. Being in the clinical stage, it does not yet have sales revenue. Its future revenue depends on the success of its lead candidate, which targets diseases for which there is currently no treatment.
Overall market sales
Quoin Pharmaceuticals is a specialty pharmaceutical company developing treatments for rare and orphan skin diseases. Demand for its products is driven solely by the medical needs of a small group of patients. This general economics has no impact on the company, which operates in an ultra-niche healthcare segment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare and orphan diseases for which there are no available treatments. Its future revenue depends on the success of clinical trials. This chart reflects analyst expectations for the commercial potential of its orphan drug portfolio.
%20sales%20of%20the%20company%20Quoin%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Quoin-Pharmaceuticals&v=1772662001524 "Schedule of future (projected) sales of the company Quoin Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma skin
Quoin Pharmaceuticals specializes in developing drugs to treat rare skin diseases. This chart shows the sales forecast for the entire dermatology drug market. Is demand for innovative therapies for orphan dermatological conditions growing? This reflects the overall potential of this niche segment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772662001532 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs to treat rare dermatological diseases. Demand for its products will be determined by patient needs and regulatory approvals, not by the economic climate. This timeline is not a significant factor for a business focused on orphan diseases.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772662001533 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on developing treatments for rare dermatological diseases for which there are no approved therapies. This chart shows its financial trajectory. Profitability depends on successful clinical trials and obtaining orphan drug designation, which can expedite approval and provide market exclusivity.
Market segment marginality - Pharma skin
Quoin Pharmaceuticals, Ltd. is a specialty pharmaceutical company focused on developing drugs for the treatment of rare dermatological diseases. This chart reflects its financial position, with profitability being a future goal dependent on success in clinical trials and the commercialization of products for niche markets.
Market marginality as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare, untreated diseases. Its business model is based on addressing unmet medical needs. This gross margin chart reflects the risk appetite investors face to fund development of orphan diseases.
Employees in the company, segment and market as a whole
Number of employees in the company Quoin Pharmaceuticals
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare dermatological diseases for which there are no approved treatments. Its small team manages the development and regulatory approval process. This chart shows how the startup focuses its resources on solving specific medical problems.
Share of the company's employees Quoin Pharmaceuticals within the market segment - Pharma skin
Quoin Pharmaceuticals is a pharmaceutical company specializing in the development of drugs for the treatment of rare dermatological diseases. Its activities are focused on clinical research and development. This graph shows the company's market share, reflecting the scale of its R&D program in this narrow and complex area of medicine.
Number of employees in the market segment - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company developing drugs for the treatment of rare and orphan dermatological diseases. The chart shows the company's presence in the skin pharmaceuticals sector. Focusing on diseases neglected by larger companies allows Quoin to occupy unique market niches.
Number of employees in the market as a whole
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare diseases with no approved treatments. Its growth depends on success in development and regulatory approval. This chart shows general trends, and Quoin is an example of a company working to solve unique medical problems by developing its scientific talent.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Quoin Pharmaceuticals (QNRX)
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare dermatological diseases. This is a niche R&D company. This chart shows how the market values their IP. It reflects the market value per employee, which is a measure of the value of their orphan disease development pipeline.
%20of%20the%20company%20Quoin%20Pharmaceuticals%20(QNRX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Quoin-Pharmaceuticals-QNRX&v=1772662001896 "Chart of market capitalization per employee (in thousands of dollars) of the company Quoin Pharmaceuticals (QNRX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Quoin Pharmaceuticals (QNRX) specializes in developing drugs for rare and orphan dermatological diseases. In this pharmaceutical niche, this metric reflects the potential of their portfolio. A high RPM may indicate that the company is targeting diseases for which there is no cure, which ensures market exclusivity and regulatory support.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772662001912 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare dermatological diseases. Its value is determined by the potential of its niche products. The chart shows a high valuation per employee, as drugs for orphan (rare) diseases can command high prices and generate significant revenue.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772662001924 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Quoin Pharmaceuticals (QNRX)
Quoin Pharmaceuticals is a clinical-stage biotech company developing drugs to treat rare skin diseases. This chart reflects its R&D workload. A negative R&D loss per employee is typical for biotech, reflecting the amount of capital invested in each scientist to conduct clinical trials.
%20Chart%20Quoin%20Pharmaceuticals%20(QNRX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Quoin-Pharmaceuticals-QNRX&v=1772662001939 "Company Profit Per Employee (in thousands of dollars) Chart Quoin Pharmaceuticals (QNRX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Quoin Pharmaceuticals, Ltd. is a specialty pharmaceutical company focused on treating rare and orphan skin diseases. In this niche, the effectiveness of a small team can be very high if successful. The graph shows the financial return per employee, which is an indicator of the potential of their drugs to address unmet medical needs.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772662001953 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Quoin Pharmaceuticals is a pharmaceutical company focused on rare dermatological diseases for which there is no cure. It's an R&D business. This chart, showing average market efficiency, provides context for evaluating the biotech model: there is no mass production; all value is created by the intellectual labor of a small group of scientists.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772662001954 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Quoin Pharmaceuticals (QNRX)
Quoin Pharmaceuticals is a pharmaceutical company focused on rare skin diseases. At the clinical stage, revenue per employee can be zero. This graph represents future potential: a successful drug for an orphan disease could command a very high price, resulting in high revenue per team member.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Quoin-Pharmaceuticals-QNRX&v=1772662001956 "Sales chart per company employee Quoin Pharmaceuticals (QNRX)")
Sales per employee in the market segment - Pharma skin
Quoin Pharmaceuticals (QNRX) is a clinical-stage biotech focused on treating rare skin diseases (dermatology). They have no commercial revenue. This chart, showing the average revenue in the sector, serves as a barometer for Quoin's R&D staffing efficiency in advancing their niche drugs.
Sales per employee for the market as a whole
Quoin Pharmaceuticals is a biotech company focused on developing drugs for rare skin diseases. Currently, their business is focused on R&D. This chart reflects their clinical stage: the company is investing in research and has no commercial sales revenue yet.
Short shares by company, segment and market as a whole
Shares shorted by company Quoin Pharmaceuticals (QNRX)
Quoin (QNRX) is a pharmaceutical company specializing in rare skin diseases. This chart tracks short positions. Short positions reflect high risk: bears are betting that the company will fail to prove the effectiveness of its drugs or obtain FDA approval for its niche products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Quoin-Pharmaceuticals-QNRX&v=1772662001970 "Short Shares Chart for the Company Quoin Pharmaceuticals (QNRX)")
Shares shorted by market segment - Pharma skin
Quoin Pharmaceuticals (QNRX) is a pharmaceutical company specializing in developing drugs to treat rare dermatological diseases for which there are no approved treatments. This chart aggregates short positions in the biotech (dermatology) sector. It reflects investor skepticism regarding the risks of clinical trials.
Shares shorted by the overall market
Quoin Pharmaceuticals is a biotech focused on rare skin diseases. This chart illustrates the overall market pessimism. For an R&D company without revenue, this is a dangerous time. Investors fear running out of cash for research, and raising a new round in this "fear market" will be impossible.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Quoin Pharmaceuticals (QNRX)
Quoin Pharmaceuticals is a biotech company focused on rare (orphan) skin diseases. It's a narrow but potentially lucrative niche. This chart measures the R&D "temperature." It "warms" with any positive news about clinical trials of their drugs, reflecting speculative interest.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Quoin-Pharmaceuticals-QNRX&v=1772662001987 "RSI 14 indicator chart for the company's stock Quoin Pharmaceuticals (QNRX)")
RSI 14 Market Segment - Pharma skin
Quoin (QNRX) is a pharmaceutical company specializing in rare dermatological diseases for which there are no approved treatments. This chart tracks the overall sentiment in the Pharma/Dermatology sector. It helps investors understand whether QNRX's performance reflects its niche or whether the entire biotech sector is overheated or oversold.
RSI 14 for the overall market
For Quoin Pharma (QNRX), a biotech company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the money supply is turned off, and companies burning through cash risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast QNRX (Quoin Pharmaceuticals)
Quoin Pharmaceuticals is a biopharmaceutical company focused on developing treatments for rare dermatological diseases for which there are no approved therapies. This chart shows the speculative average 12-month price target from analysts, which is almost entirely based on their assessment of the company's R&D portfolio.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-QNRX-Quoin-Pharmaceuticals&v=1772662002011 "A chart showing analyst consensus forecasts for the expected stock price. QNRX (Quoin Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price QNRX (Quoin Pharmaceuticals)
Quoin Pharmaceuticals is a biotech company focused on developing drugs for rare dermatological diseases. This chart shows the difference between the market valuation and the analyst consensus estimate. For an R&D company, this gap reflects experts' confidence in their scientific platform and the chances of approval in this niche.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-QNRX-Quoin-Pharmaceuticals&v=1772662002075 "A chart showing the difference between the consensus forecast and the actual stock price. QNRX (Quoin Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Quoin Pharmaceuticals is a biotech R&D company focused on developing drugs for rare skin diseases (dermatology). This chart reflects analysts' overall expectations for the entire skin pharma sector. It shows whether experts believe junior biotechs can succeed in this niche.
Analysts' consensus forecast for the overall market share price
Quoin Pharmaceuticals is a biotech company specializing in developing drugs to treat rare skin diseases. This chart shows the overall market "risk appetite." For QNRX, a high-risk clinical-stage company, overall market optimism (an upward trend in the chart) is critical for raising capital for R&D.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Quoin Pharmaceuticals
Quoin Pharma is a biotech company focused on ultra-orphan skin diseases. Their specialty is R&D for drugs that treat diseases that affect very few patients (for example, Netherton syndrome). This graph is a pure indicator of their R&D. Its dynamics depend entirely on their (very risky) clinical trial data and their chances of approval.
AKIMA Market Segment Index - Pharma skin
Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare skin diseases (dermatology), for which there are often no approved treatments. This chart helps investors understand their relative position by comparing the company's comprehensive index to the sector average. This shows whether they are outperforming their competitors in their niche.
The AKIM Index for the overall market
Quoin Pharmaceuticals is a pharmaceutical company focused on treating rare and orphan skin diseases (Netherton syndrome). This chart, which reflects the market average, provides a macro backdrop. It helps assess how QNRX, a niche dermatology company, compares to overall economic trends.
